300255 常山药业
已收盘 08-20 15:00:00
资讯
新帖
简况
8月19日常山药业跌5.76%,创业板医药ETF国泰基金重仓该股
证券之星 · 08-19 17:06
8月19日常山药业跌5.76%,创业板医药ETF国泰基金重仓该股
常山药业:截至2026年8月10日,公司的股东户数为70629户
证券之星 · 08-13
常山药业:截至2026年8月10日,公司的股东户数为70629户
常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作
证券之星 · 08-13
常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作
8月7日常山药业涨8.66%,创业板医药ETF国泰基金重仓该股
证券之星 · 08-07
8月7日常山药业涨8.66%,创业板医药ETF国泰基金重仓该股
常山药业(300255)披露产品拟中选第十二批国家组织药品集中带量采购,8月3日股价上涨1.0%
证券之星 · 08-03
常山药业(300255)披露产品拟中选第十二批国家组织药品集中带量采购,8月3日股价上涨1.0%
常山药业:截至2026年7月31日股东户数为61797户
证券之星 · 08-03
常山药业:截至2026年7月31日股东户数为61797户
常山药业:正在积极推进艾本那肽补充资料工作
证券之星 · 08-03
常山药业:正在积极推进艾本那肽补充资料工作
7月24日常山药业跌7.98%,创业板医药ETF国泰基金重仓该股
证券之星 · 07-24
7月24日常山药业跌7.98%,创业板医药ETF国泰基金重仓该股
常山药业:不存在“功能性治愈”二型糖尿病
证券之星 · 07-22
常山药业:不存在“功能性治愈”二型糖尿病
常山药业(300255)7月20日股东户数7.68万户,较上期增加47.99%
证券之星 · 07-21
常山药业(300255)7月20日股东户数7.68万户,较上期增加47.99%
常山药业:截至2026年7月20日,公司的股东户数为76810户
证券之星 · 07-21
常山药业:截至2026年7月20日,公司的股东户数为76810户
常山药业:公司正在根据审评要求积极稳步推进补充资料相关工作
证券之星 · 07-21
常山药业:公司正在根据审评要求积极稳步推进补充资料相关工作
7月20日常山药业跌5.38%,创业板医药ETF国泰基金重仓该股
证券之星 · 07-20
7月20日常山药业跌5.38%,创业板医药ETF国泰基金重仓该股
常山药业(300255)披露股票交易异常波动公告,7月17日股价上涨0.19%
证券之星 · 07-17
常山药业(300255)披露股票交易异常波动公告,7月17日股价上涨0.19%
7月17日常山药业(300255)龙虎榜数据:机构净买入2618.56万元(3日),北向资金净卖出6254.07万元(3日)
证券之星 · 07-17
7月17日常山药业(300255)龙虎榜数据:机构净买入2618.56万元(3日),北向资金净卖出6254.07万元(3日)
常山药业:艾本那肽最终能否获批上市及获批时间仍存在不确定性
格隆汇 · 07-17
常山药业:艾本那肽最终能否获批上市及获批时间仍存在不确定性
7月15日常山药业涨13.71%,创业板医药ETF国泰基金重仓该股
证券之星 · 07-15
7月15日常山药业涨13.71%,创业板医药ETF国泰基金重仓该股
常山药业(300255)7月10日股东户数5.19万户,较上期减少1.75%
证券之星 · 07-13
常山药业(300255)7月10日股东户数5.19万户,较上期减少1.75%
常山药业:公司始终坚持做好主业经营
证券之星 · 07-13
常山药业:公司始终坚持做好主业经营
常山药业:本轮人员调整是公司基于市场环境变化、业务结构优化及内部精益经营管理做出的安排
证券之星 · 07-13
常山药业:本轮人员调整是公司基于市场环境变化、业务结构优化及内部精益经营管理做出的安排
加载更多
公司概况
公司名称:
河北常山生化药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-08-19
主营业务:
河北常山生化药业股份有限公司的主营业务是肝素系列产品的研发、生产和销售。公司的主要产品是普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司近几年分别被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等,建立了国家级博士后科研工作站,有效推动公司高级人才引进和创新驱动发展。
发行价格:
28.00
{"stockData":{"symbol":"300255","market":"SZ","secType":"STK","nameCN":"常山药业","latestPrice":25.55,"timestamp":1787209401000,"preClose":25.02,"halted":0,"volume":46768801,"delay":0,"changeRate":0.0212,"floatShares":918000000,"shares":919000000,"eps":-0.3872,"marketStatus":"已收盘","change":0.53,"latestTime":"08-20 15:00:00","open":25.65,"high":26.92,"low":25.3,"amount":1219000000,"amplitude":0.0647,"askPrice":25.55,"askSize":449,"bidPrice":25.54,"bidSize":248,"shortable":0,"etf":0,"ttmEps":-0.3872,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787275800000},"marketStatusCode":5,"adr":0,"adjPreClose":25.02,"symbolType":"stock","openAndCloseTimeList":[[1787189400000,1787196600000],[1787202000000,1787209200000]],"highLimit":27.52,"lowLimit":22.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":919060878,"isCdr":false,"pbRate":19,"roa":"--","roe":"0.49%","epsLYR":-0.39,"committee":-0.363123,"marketValue":23482000000,"turnoverRate":0.051,"status":0,"floatMarketCap":23445000000},"requestUrl":"/m/hq/s/300255","defaultTab":"news","newsList":[{"id":"2660744604","title":"8月19日常山药业跌5.76%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660744604","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660744604?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:06","pubTimestamp":1787130390,"startTime":"0","endTime":"0","summary":"证券之星消息,8月19日常山药业跌5.76%,收盘报25.02元,换手率3.8%,成交量34.83万手,成交额8.88亿元。重仓常山药业的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900029099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659095181","title":"常山药业:截至2026年8月10日,公司的股东户数为70629户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659095181","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659095181?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:54","pubTimestamp":1786582453,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2026年8月 10日公司的股东户数是多少?谢谢常山药业回复:尊敬的投资者,您好!截至2026年8月10日,公司的股东户数为70629户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0070","BK0172","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659181054","title":"常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2659181054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659181054?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:54","pubTimestamp":1786582448,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业08月12日在投资者关系平台上答复投资者关心的问题。新药NDA审评周期受多重因素影响,审评周期长短不直接等同于审评结果。公司正在根据审评要求积极稳步推进艾本那肽的补充资料相关工作,目前尚未完成上述工作,审评进度及最终结果,请以公司后续披露的官方公告为准。公司将持续跟进审评进展,后续如发生重大进展,公司将按照监管规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616105","title":"8月7日常山药业涨8.66%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616105?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:48","pubTimestamp":1786092491,"startTime":"0","endTime":"0","summary":"证券之星消息,8月7日常山药业涨8.66%,收盘报28.11元,换手率8.27%,成交量75.85万手,成交额20.53亿元。重仓常山药业的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656778603","title":"常山药业(300255)披露产品拟中选第十二批国家组织药品集中带量采购,8月3日股价上涨1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656778603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656778603?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:17","pubTimestamp":1785766628,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,常山药业报收于25.21元,较前一交易日上涨1.0%,最新总市值为231.7亿元。近日,河北常山生化药业股份有限公司发布《关于公司产品拟中选第十二批国家组织药品集中带量采购的公告》。公告显示,公司产品达肝素钠注射液拟中选第十二批国家组织药品集中带量采购,拟中选产品包括0.2ml:5000IU和0.3ml:7500IU两个规格,适应症涵盖治疗急性深静脉血栓、血液透析期间预防凝血、治疗不稳定型冠状动脉疾病及术后血栓预防。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0070","BK0239","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656326732","title":"常山药业:截至2026年7月31日股东户数为61797户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656326732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656326732?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:27","pubTimestamp":1785742038,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请问截止7月30日的股东人数常山药业回复:尊敬的投资者,您好!截至2026年7月31日,公司的股东户数为61797户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656267623","title":"常山药业:正在积极推进艾本那肽补充资料工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2656267623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656267623?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:27","pubTimestamp":1785742037,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业08月03日在投资者关系平台上答复投资者关心的问题。发补资料难易程度如何?公司正在根据审评要求积极稳步推进艾本那肽的补充资料相关工作,目前尚未完成上述工作。公司将密切跟进审评进展,严格遵照监管要求及信息披露规则,及时披露后续相关重要进展,感谢您的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653001897","title":"7月24日常山药业跌7.98%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653001897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653001897?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:51","pubTimestamp":1784883102,"startTime":"0","endTime":"0","summary":"证券之星消息,7月24日常山药业跌7.98%,收盘报25.25元,换手率5.25%,成交量48.16万手,成交额12.6亿元。重仓常山药业的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0172","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653576843","title":"常山药业:不存在“功能性治愈”二型糖尿病","url":"https://stock-news.laohu8.com/highlight/detail?id=2653576843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653576843?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:57","pubTimestamp":1784725027,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业07月21日在投资者关系平台上答复投资者关心的问题。实现“功能性治愈”二型糖尿病?2型糖尿病属于慢性代谢性疾病,目前不存在医学与监管认可的“功能性治愈”,公司也未开展所谓“功能性治愈2型糖尿病”的临床研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200045314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0172","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653275154","title":"常山药业(300255)7月20日股东户数7.68万户,较上期增加47.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653275154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653275154?lang=zh_cn&edition=full","pubTime":"2026-07-21 18:01","pubTimestamp":1784628096,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年7月20日公司股东户数为7.68万户,较7月10日增加2.49万户,增幅为47.99%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至7月20日,化学制药行业平均股东户数为3.58万户。从股价来看,2026年7月10日至2026年7月20日,常山药业区间涨幅为14.09%,在此期间股东户数增加2.49万户,增幅为47.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100033661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK0172","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653279532","title":"常山药业:截至2026年7月20日,公司的股东户数为76810户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653279532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653279532?lang=zh_cn&edition=full","pubTime":"2026-07-21 16:09","pubTimestamp":1784621350,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问:截至目前,股东人数是多少?常山药业回复:尊敬的投资者,您好!截至2026年7月20日,公司的股东户数为76810户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100029248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0070","BK0172","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653222626","title":"常山药业:公司正在根据审评要求积极稳步推进补充资料相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653222626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653222626?lang=zh_cn&edition=full","pubTime":"2026-07-21 15:34","pubTimestamp":1784619277,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请问截止今天,公司是否已经准备好阿贝那肽发补资料?资料准备难易程度如何?常山药业回复:尊敬的投资者,您好!公司正在根据审评要求积极稳步推进补充资料相关工作,目前尚未完成上述工作。后续进展公司将严格根据信息披露规则,依法依规及时履行披露义务。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100023621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652296063","title":"7月20日常山药业跌5.38%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652296063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652296063?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:45","pubTimestamp":1784537138,"startTime":"0","endTime":"0","summary":"证券之星消息,7月20日常山药业跌5.38%,收盘报30.05元,换手率8.2%,成交量75.26万手,成交额22.46亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000025064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0172","160219","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652228999","title":"常山药业(300255)披露股票交易异常波动公告,7月17日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652228999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652228999?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:26","pubTimestamp":1784298374,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,常山药业报收于31.76元,较前一交易日上涨0.19%,最新总市值为291.89亿元。该股当日开盘30.66元,最高33.59元,最低29.0元,成交额达32.18亿元,换手率为11.31%。公司于2026年7月17日披露《股票交易异常波动公告》称,其股票连续三个交易日收盘价格涨幅偏离值累计超过30%,构成异常波动。公司2025年度营业收入同比下降15.10%,净利润为亏损35,789.56万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700044924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300255","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652061401","title":"7月17日常山药业(300255)龙虎榜数据:机构净买入2618.56万元(3日),北向资金净卖出6254.07万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2652061401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652061401?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:46","pubTimestamp":1784281596,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年7月17日公布的交易公开信息显示,常山药业因连续三个交易日内,涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月17日收盘,常山药业报收于31.76元,上涨0.19%,换手率11.31%,成交量103.78万手,成交额32.18亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入2618.56万元,北向资金合计净卖出6254.07万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700032797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652066614","title":"常山药业:艾本那肽最终能否获批上市及获批时间仍存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2652066614","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652066614?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:27","pubTimestamp":1784276851,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300255","BK0172","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651537064","title":"7月15日常山药业涨13.71%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651537064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651537064?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:33","pubTimestamp":1784104429,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日常山药业涨13.71%,收盘报28.7元,换手率10.19%,成交量93.55万手,成交额26.1亿元。重仓常山药业的公募基金请见下表:根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","BK0239","160219","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419001","title":"常山药业(300255)7月10日股东户数5.19万户,较上期减少1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419001","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651419001?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:51","pubTimestamp":1783936313,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年7月10日公司股东户数为5.19万户,较6月18日减少927.0户,减幅为1.75%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至7月10日,化学制药行业平均股东户数为3.56万户。从股价来看,2026年6月18日至2026年7月10日,常山药业区间涨幅为1.9%,在此期间股东户数减少927.0户,减幅为1.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651998201","title":"常山药业:公司始终坚持做好主业经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2651998201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651998201?lang=zh_cn&edition=full","pubTime":"2026-07-13 15:03","pubTimestamp":1783926192,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业07月13日在投资者关系平台上答复投资者关心的问题。公司始终高度重视市值管理与投资者价值维护工作,制定了《市值管理制度》。公司始终坚持做好主业经营,持续推进研发与商业化运营,并努力通过盈利能力回升、加强投资者交流等方式,提升内在价值和投资者回报。公司目前生产经营一切正常,不存在重大经营风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300015280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651019989","title":"常山药业:本轮人员调整是公司基于市场环境变化、业务结构优化及内部精益经营管理做出的安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2651019989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651019989?lang=zh_cn&edition=full","pubTime":"2026-07-13 15:00","pubTimestamp":1783926047,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业07月13日在投资者关系平台上答复投资者关心的问题。公司人员变动受多重因素影响,目前核心研发、技术与管理团队整体稳定。总体来看,本轮人员调整是公司基于市场环境变化、业务结构优化及内部精益经营管理做出的安排,并非技术冲击、成本异常波动或内部治理问题导致。公司未来人员相关情况请您关注公司后续披露的定期报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300015252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787272897591,"stockEarnings":[{"period":"1week","weight":-0.0988},{"period":"1month","weight":-0.1051},{"period":"3month","weight":-0.3719},{"period":"6month","weight":-0.4082},{"period":"1year","weight":-0.4686},{"period":"ytd","weight":-0.5886}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河北常山生化药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"70629人(较上一季度增加14.29%)","perCapita":"12992股","listingDate":"2011-08-19","address":"河北省石家庄市正定县中国(河北)自由贸易试验区正定片区高新技术产业开发区南区梦龙街71号","registeredCapital":"91906万元","survey":" 河北常山生化药业股份有限公司的主营业务是肝素系列产品的研发、生产和销售。公司的主要产品是普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司近几年分别被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等,建立了国家级博士后科研工作站,有效推动公司高级人才引进和创新驱动发展。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"常山药业,300255,常山药业股票,常山药业股票老虎,常山药业股票老虎国际,常山药业行情,常山药业股票行情,常山药业股价,常山药业股市,常山药业股票价格,常山药业股票交易,常山药业股票购买,常山药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}